The May DCI Seminar Series will be held Wednesday, May 24, at the Great Hall located in the Trent Seamans Center. Webster Cavenee, PhD, director of Strategic Alliances in the Center Nervous System Cancers, Ludwig Institute for Cancer Research, University of California, San Diego, will present: "A Dynamic Episomal Basis for Tumor Heterogenity."
Cavenee received his bachelor's and doctoral degrees from the University of Kansas. He has held faculty positions at the University of Cincinnati and McGill University (where he was the founding director of the Ludwig Institute for Cancer Research, Montreal Branch). From 1991 to 2015 Cavenee served as the founding director of the Ludwig Institute for Cancer Research and Distinguished Professor of Medicine at the University of California at San Diego. Since 2015, he has served as director, Strategic Alliances-CNS of Ludwig Cancer Research where he has global responsibilities.
Cavenee's research focuses on oncogenic and suppressive mutations in the genesis and progression of human tumors, particularly those of the central nervous system, and their influence on therapeutic response. This work involves cellular genetics, engineered mouse models, protein biochemistry and tumor biology. Cavenee’s most recognized accomplishments are in the genetic basis of cancer predisposition, tumor progression, oncogenic cellular signaling and the use of genetic approaches for cancer diagnosis and prognosis. He has served on many NIH review and advisory panels including the Boards of Scientific Counselors of the National Cancer Institute and the National Institute of Environmental Health Sciences and advisory boards for several NIH Cancer Center Support, SPORE and PO1 grants, as well those of several private foundations and international institutions. He has been President of the American Association for Cancer Research.
The lecture begins at 8:10 a.m. and ends at 9 a.m. Cavenee's address will be preceded by a hematology-oncology fellow presentation starting at 7:30 a.m. The May DCI Seminar Series is presented by the DCI Neuro-Oncology Program. Duke Cancer Institute members are invited to attend. For more information, contact Erin Carr.